Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | APP | P05067 | 2/20 | 0.33 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21160620 | 0.84 | L3MBTL1 (0.40) | L3MBTL1APPMEN1ALDH1A1MAPT | |
| SCHEMBL21037254 | 0.82 | MEN1 (0.45) | L3MBTL1MEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL24089767 | 0.74 | MAPT (0.53) | MEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL21037329 | 0.74 | MAPT (0.48) | L3MBTL1APPRPS6KA3MEN1ALDH1A1 | |
| SCHEMBL22295750 | 0.74 | L3MBTL1 (0.40) | L3MBTL1APP | |
| SCHEMBL22314205 | 0.73 | APP (0.41) | APPRPS6KA3MEN1ALDH1A1MAPT | |
| SCHEMBL24089680 | 0.72 | APP (0.38) | APPRPS6KA3MEN1ALDH1A1MAPT | |
| SCHEMBL21036838 | 0.71 | L3MBTL1 (0.41) | L3MBTL1APPMEN1ALDH1A1MAPT | |
| SCHEMBL21037003 | 0.71 | MEN1 (0.50) | L3MBTL1MEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL21037850 | 0.71 | MEN1 (0.46) | L3MBTL1MEN1ALDH1A1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11209437-B2 | Fluorescent probe and preparation method and use thereof | FLUORESCENCE DIAGNOSIS (SHANGHAI) BIOTECH COMPANY (CN) | 2021-12-28 | — | — | US | disclosed |
| US-20190187144-A1 | FLUORESCENT PROBE AND PREPARATION METHOD AND USE THEREOF | EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2019-06-20 | — | — | US | disclosed |
| EP-3489324-A1 | FLUORESCENT PROBE AND PREPARATION METHOD AND USE THEREOF | East China University of Science and Technology (CN) | 2019-05-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190187144-A1 | FLUORESCENT PROBE AND PREPARATION METHOD AND USE THEREOF | HNRNPF, HNRNPUL2, RAB5IF | L3MBTL1 616/4885APP 2001/4885RPS6KA3 2845/4885 |
| US-11209437-B2 | Fluorescent probe and preparation method and use thereof | HNRNPF, HNRNPUL2, RAB5IF | L3MBTL1 616/4885APP 2001/4885RPS6KA3 2845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.